Veracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.68 million versus the consensus estimate of $14.81 million.

For earnings history and earnings-related data on Veracyte (VCYT) click here.